Cargando…

Enhanced Anti-Tumoral Activity of Methotrexate-Human Serum Albumin Conjugated Nanoparticles by Targeting with Luteinizing Hormone-Releasing Hormone (LHRH) Peptide

Active targeting could increase the efficacy of anticancer drugs. Methotrexate-human serum albumin (MTX-HSA) conjugates, functionalized by luteinizing hormone-releasing hormone (LHRH) as targeting moieties, with the aim of specifically targeting the cancer cells, were prepared. Owing to the high exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taheri, Azade, Dinarvand, Rassoul, Atyabi, Fatemeh, Ahadi, Fatemeh, Nouri, Farank Salman, Ghahremani, Mohammad Hossein, Ostad, Seyed Nasser, Borougeni, Atefeh Taheri, Mansoori, Pooria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155371/ https://www.ncbi.nlm.nih.gov/pubmed/21845098 http://dx.doi.org/10.3390/ijms12074591

Ejemplares similares

Use of biotin targeted methotrexate–human serum albumin conjugated nanoparticles to enhance methotrexate antitumor efficacy
por: Taheri, Azade, et al.
Publicado: (2011)

Healing Efficacy of an EGF Impregnated Triple Gel Based Wound Dressing: In Vitro and In Vivo Studies
por: Khanbanha, Najmeh, et al.
Publicado: (2014)

Expression of Luteinizing Hormone-Releasing Hormone (LHRH) and Type-I LHRH Receptor in Transitional Cell Carcinoma Type of Human Bladder Cancer
por: Szabó, Zsuzsanna, et al.
Publicado: (2021)

Enhanced Oral Delivery of Docetaxel Using Thiolated Chitosan Nanoparticles: Preparation, In Vitro and In Vivo Studies
por: Saremi, Shahrooz, et al.
Publicado: (2013)

Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma
por: Treszl, Andrea, et al.
Publicado: (2013)

Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation
por: Saremi, Shahrooz, et al.
Publicado: (2011)

Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study
por: Hosseinzadeh, Hosniyeh, et al.
Publicado: (2012)

Luteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomes
por: He, Yingna, et al.
Publicado: (2010)

Synthesis of Radiolabeled Technetium- and Rhenium-Luteinizing Hormone-Releasing Hormone ((99m)Tc/Re-Acdien-LHRH) Conjugates for Targeted Detection of Breast Cancer Cells Overexpressing the LHRH Receptor
por: Calderon, Lindsay E., et al.
Publicado: (2021)

Transformation of a prostatic adenocarcinoma into squamous cell carcinoma after luteinizing hormone-releasing hormone (LHRH) agonist and radiotherapy treatment
por: Ichaoui, Hamza, et al.
Publicado: (2019)

Docetaxel immunonanocarriers as targeted delivery systems for HER 2-positive tumor cells: preparation, characterization, and cytotoxicity studies
por: Koopaei, Mona Noori, et al.
Publicado: (2011)

Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel
por: Manoochehri, Saeed, et al.
Publicado: (2013)

Nonrandomized Comparison of Efficacy and Side Effects of Bicalutamide Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Analogs in Combination With Radiation Therapy in the CHHiP Trial
por: Tree, Alison, et al.
Publicado: (2022)

Appropriate Scaffold Selection for CNS Tissue Engineering
por: Shafiee, Akram, et al.
Publicado: (2020)

Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells
por: Talaei, Fatemeh, et al.
Publicado: (2011)

Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles
por: Esfandyari-Manesh, Mehdi, et al.
Publicado: (2015)

Brain targeted delivery of rapamycin using transferrin decorated nanostructured lipid carriers
por: Khonsari, Fatemeh, et al.
Publicado: (2022)

Correction: Brain targeted delivery of rapamycin using transferrin decorated nanostructured lipid carriers
por: Khonsari, Fatemeh, et al.
Publicado: (2022)

Application of nanostructured lipid carriers: the prolonged protective effects for sesamol in in vitro and in vivo models of ischemic stroke via activation of PI3K signalling pathway
por: Hassanzadeh, Parichehr, et al.
Publicado: (2017)

A conjugate of methotrexate and an analog of luteinizing hormone releasing hormone shows increased efficacy against prostate cancer
por: Zhu, Shengsheng, et al.
Publicado: (2016)

Human Serum Albumin Conjugates of 7-Ethyl-10-hydroxycamptothecin (SN38) for Cancer Treatment
por: Sepehri, Nima, et al.
Publicado: (2014)

Polyanionic carbohydrate doxorubicin–dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations
por: Yousefpour, Parisa, et al.
Publicado: (2011)

Preparation and In-vitro Evaluation of Controlled Release PLGA Microparticles Containing Triptoreline
por: Mahboubian, Alireza, et al.
Publicado: (2010)

Contemporary hormone therapy with LHRH agonists for prostate cancer: avoiding osteoporosis and fracture
por: Wilson, Hannah C.P., et al.
Publicado: (2015)

Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy
por: Vakhshiteh, Faezeh, et al.
Publicado: (2019)

Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome
por: Liu, Nana, et al.
Publicado: (2012)

Characterization of Luteinizing Hormone and Luteinizing Hormone Receptor and Their Indispensable Role in the Ovulatory Process of the Medaka
por: Ogiwara, Katsueki, et al.
Publicado: (2013)

Modified Gadonanotubes as a promising novel MRI contrasting agent
por: Jahanbakhsh, Rouzbeh, et al.
Publicado: (2013)

Follicular-Stimulating Hormone, Luteinizing Hormone, and Prolactin Serum Level in Patients with Oral Lichen Planus in Comparison to Healthy Population
por: Lavaee, Fatemeh, et al.
Publicado: (2021)

Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab
por: Yousefpour, Parisa, et al.
Publicado: (2011)

Targeted cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), AEZS-108 (AN-152), inhibits the growth of DU-145 human castration-resistant prostate cancer in vivo and in vitro through elevating p21 and ROS levels
por: Popovics, Petra, et al.
Publicado: (2014)

Targeting Tumorigenicity of Breast Cancer Stem Cells Using SAHA/Wnt-b Catenin Antagonist Loaded Onto Protein Corona of Gold Nanoparticles
por: Shamsian, Azam, et al.
Publicado: (2020)

Biodistribution of Cy5-labeled Thiolated and Methylated Chitosan-Carboxymethyl Dextran Nanoparticles in an Animal Model of Retinoblastoma
por: Delrish, Elham, et al.
Publicado: (2022)

Erratum: Biodistribution of Cy5-labeled Thiolated and Methylated Chitosan-Carboxymethyl Dextran Nanoparticles in an Animal Model of Retinoblastoma
por: Delrish, Elham, et al.
Publicado: (2022)

Response of the corpus luteum to luteinizing hormone.
por: Niswender, G D
Publicado: (1981)

Cationic graphene oxide nanoplatform mediates miR-101 delivery to promote apoptosis by regulating autophagy and stress
por: Assali, Akram, et al.
Publicado: (2018)

Hormonal treatment of pancreatic carcinoma: a phase II study of LHRH agonist goserelin plus hydrocortisone.
por: Philip, P. A., et al.
Publicado: (1993)

Luteinizing Hormone-Releasing Hormone Distribution in the Anterior Hypothalamus of the Female Rats
por: Castañeyra-Ruiz, Leandro, et al.
Publicado: (2013)

The utilization of basal luteinizing hormone in combination with the basal luteinizing hormone and follicle-stimulating hormone ratio as a diagnostic tool for central precocious puberty in girls
por: Chotipakornkul, Nuntika, et al.
Publicado: (2023)

Controlling evolution of protein corona: a prosperous approach to improve chitosan-based nanoparticle biodistribution and half-life
por: Tekie, Farnaz Sadat Mirzazadeh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ugisg14cpt3lt3kvcor4e4b11k